Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Natural killer (NK) cells represent a promising cell type in antitumor immunotherapy for efficacy and safety, particularly in the treatment of hematologic malignancies. NK cells have been shown to exert antileukemia activity in the context of haploidentical hematopoietic stem cell transplantation (h...

Descripción completa

Detalles Bibliográficos
Autores principales: Colomar-Carando, Natalia, Gauthier, Laurent, Merli, Pietro, Loiacono, Fabrizio, Canevali, Paolo, Falco, Michela, Galaverna, Federica, Rossi, Benjamin, Bosco, Frédéric, Caratini, Mélody, Mingari, Maria Cristina, Locatelli, Franco, Vivier, Eric, Meazza, Raffaella, Pende, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662914/
https://www.ncbi.nlm.nih.gov/pubmed/35078821
http://dx.doi.org/10.1158/2326-6066.CIR-21-0843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662914/
https://www.ncbi.nlm.nih.gov/pubmed/35078821
http://dx.doi.org/10.1158/2326-6066.CIR-21-0843

Ejemplares similares